Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, agosto 19
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
MMTEC Inc
MTC
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$3.10
-0.01
-0.32%
al cierre: Aug 19, 5:00 PM EST
$3.00
-0.10
-3.23%
After hour: Aug 14, 4:41 AM EST
Get Report
Panorámica general
Noticias
Previsión de beneficios
Finanzas
Sentimiento
Comparar
Informe de acciones
MMTEC Financials
MMTEC (MTC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
US Stocks Edge Higher; PepsiCo Cuts 2024 Revenue Outlook
Avi Kapoor
Dow Dips Over 100 Points; US Jobless Claims Increase To 225,000
Avi Kapoor
Crude Oil Edges Higher; ConAgra Posts Downbeat Earnings
Avi Kapoor
Dow Surges Over 50 Points; Disney Earnings Top Views
Avi Kapoor
PRO
MMTEC H1 EPS $(0.30) Up From $(0.92) YoY, Sales $2.86M Up From $733.40K YoY
MMTEC (NASDAQ:MTC) reported quarterly losses of $(0.30) per share. This is a 67.39 percent increase over losses of $(0.92) per share from the same period last year. The company reported $2.86 million in sales this
Benzinga Newsdesk
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.
Lisa Levin
Privacy Manager